cupure logo

Novo Nordisk Stock Plummets After Ozempic-Maker’s Alzheimer’s Drug Trial Fails

The company said the weight loss and diabetes treatment drug failed to show any significant reduction in the progression of Alzheimer's disease in patients.

Comments

Business News